| Name: | BIOMEDICA MANAGEMENT CORPORATION |
| Jurisdiction: | New York |
| Legal type: | DOMESTIC BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 09 Aug 1999 (26 years ago) |
| Entity Number: | 2406866 |
| ZIP code: | 11228 |
| County: | New York |
| Place of Formation: | New York |
| Principal Address: | 1448 SOUTH ROLLING RD, #123, HALETHORPE, MD, United States, 21227 |
| Address: | 7014 13TH AVENUE, SUITE 202, BROOKLYN, NY, United States, 11228 |
Shares Details
Shares issued 12512400
Share Par Value 0.01
Type PAR VALUE
| Name | Role | Address |
|---|---|---|
| UNITED STATES CORPORATION AGENTS, INC. | Agent | 7014 13TH AVENUE, SUITE 202, BROOKLYN, NY, 11228 |
| Name | Role | Address |
|---|---|---|
| C/O UNITED STATES CORPORATION AGENTS, INC. | DOS Process Agent | 7014 13TH AVENUE, SUITE 202, BROOKLYN, NY, United States, 11228 |
| Name | Role | Address |
|---|---|---|
| GEORGE D FALUS | Chief Executive Officer | 760 PARKSIDE AVENUE, ROOM 304, BROOKLYN, NY, United States, 11226 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2011-08-30 | 2015-05-29 | Address | 760 PARKSIDE AVENUE, ROOM 304, BROOKLYN, NY, 11226, USA (Type of address: Principal Executive Office) |
| 2011-08-30 | 2016-11-22 | Address | 760 PARKSIDE AVENUE, ROOM 304, BROOKLYN, NY, 11226, USA (Type of address: Service of Process) |
| 2008-12-22 | 2011-08-30 | Address | 760 PARKSIDE AVENUE, RM 210, BROOKLYN, NY, 11226, USA (Type of address: Principal Executive Office) |
| 2008-12-22 | 2011-08-30 | Address | 760 PARKSIDE AVENUE, RM 210, BROOKLYN, NY, 11226, USA (Type of address: Service of Process) |
| 2008-12-22 | 2011-08-30 | Address | 760 PARKSIDE AVENUE, RM 210, BROOKLYN, NY, 11226, USA (Type of address: Chief Executive Officer) |
| 2005-10-20 | 2008-12-22 | Address | 135 W 41ST ST, STE 608, NEW YORK, NY, 10036, 7804, USA (Type of address: Principal Executive Office) |
| 2005-10-20 | 2008-12-22 | Address | 130 W 42ND ST, NEW YORK, NY, 10036, 7804, USA (Type of address: Chief Executive Officer) |
| 2005-10-20 | 2008-12-22 | Address | 135 W 41ST ST, STE 608, NEW YORK, NY, 10036, 7804, USA (Type of address: Service of Process) |
| 2004-11-12 | 2015-06-02 | Shares | Share type: PAR VALUE, Number of shares: 1010, Par value: 100 |
| 2001-08-20 | 2005-10-20 | Address | 130 W 42ND ST, NEW YORK, NY, 10036, USA (Type of address: Principal Executive Office) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 161122000298 | 2016-11-22 | CERTIFICATE OF CHANGE | 2016-11-22 |
| 150602000098 | 2015-06-02 | CERTIFICATE OF AMENDMENT | 2015-06-02 |
| 150529002051 | 2015-05-29 | AMENDMENT TO BIENNIAL STATEMENT | 2013-08-01 |
| 130822006276 | 2013-08-22 | BIENNIAL STATEMENT | 2013-08-01 |
| 110830002798 | 2011-08-30 | BIENNIAL STATEMENT | 2011-08-01 |
| 090812002382 | 2009-08-12 | BIENNIAL STATEMENT | 2009-08-01 |
| 081222002672 | 2008-12-22 | BIENNIAL STATEMENT | 2007-08-01 |
| 080813000427 | 2008-08-13 | CERTIFICATE OF AMENDMENT | 2008-08-13 |
| 051020002860 | 2005-10-20 | BIENNIAL STATEMENT | 2005-08-01 |
| 041112000804 | 2004-11-12 | CERTIFICATE OF AMENDMENT | 2004-11-12 |
| Contract Type | Award or IDV Flag | PIID | Start Date | Current End Date | Potential End Date | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEFINITIVE CONTRACT | AWARD | W31P4Q08C0218 | 2008-02-14 | 2008-10-08 | 2008-10-08 | |||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
| Obligated Amount | 98957.00 |
| Current Award Amount | 98957.00 |
| Potential Award Amount | 98957.00 |
Description
| Title | DARPA SBIR PHASE 1 |
| NAICS Code | 541712: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) |
| Product and Service Codes | AD92: OTHER DEFENSE (APPLIED/EXPLORATORY) |
Recipient Details
| Recipient | BIOMEDICA MANAGEMENT CORP |
| UEI | HXAWJKQ9KNV4 |
| Legacy DUNS | 146587345 |
| Recipient Address | UNITED STATES, 130 W 42ND ST STE 608, NEW YORK, NEW YORK, NEW YORK, 100367804 |
| Unique Award Key | CONT_AWD_W81XWH09C0035_9700_-NONE-_-NONE- |
| Awarding Agency | Department of Defense |
| Link | View Page |
Award Amounts
| Obligated Amount | 69998.03 |
| Current Award Amount | 69998.03 |
| Potential Award Amount | 119997.67 |
Description
| Title | SBIR PHASE I RAD II/USAISR/A083-176-0100 |
| NAICS Code | 541712: RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) |
| Product and Service Codes | AN91: OTHER MEDICAL (BASIC) |
Recipient Details
| Recipient | BIOMEDICA MANAGEMENT CORP |
| UEI | HXAWJKQ9KNV4 |
| Legacy DUNS | 146587345 |
| Recipient Address | UNITED STATES, 130 W 42ND ST STE 608, NEW YORK, NEW YORK, NEW YORK, 100367804 |
| FAIN | Awarding Agency | Assistance Listings | Start Date | End Date | Description | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| W81XWH1020123 | Department of Defense | 12.420 - MILITARY MEDICAL RESEARCH AND DEVELOPMENT | 2010-10-01 | 2011-10-31 | EFFECTIVENESS AND SAFETY OF NON-COMPRESSIBLE HEMOSTATIC AGENT CLOTFOAM IN CASES OF TRAUMATIC WOUNDS AND INTRACAVITARY BLEEDING IN THE BATTLEFIELD | |||||||||||||||||||||
|
||||||||||||||||||||||||||
| R43AI080001 | Department of Health and Human Services | 93.855 - ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH | 2008-09-01 | 2009-02-28 | IMMUNOMODULATION OF SOPHOROLIPIDS IN SEPSIS | |||||||||||||||||||||
|
||||||||||||||||||||||||||
| R43GM081934 | Department of Health and Human Services | 93.859 - BIOMEDICAL RESEARCH AND RESEARCH TRAINING | 2007-09-05 | 2008-09-30 | ANTI-ISCHEMIC RESUSCITATION FLUID | |||||||||||||||||||||
|
||||||||||||||||||||||||||
| R44HL086293 | Department of Health and Human Services | 93.839 - BLOOD DISEASES AND RESOURCES RESEARCH | 2006-05-01 | 2011-05-31 | INTRACAVITARY HEMOSTATIC AGENT FOR NON-COMPRESSIBLE HEMORRHAGE | |||||||||||||||||||||
|
||||||||||||||||||||||||||
Date of last update: 31 Mar 2025
Sources: New York Secretary of State
